ProSystem RCEThis page contains information on ProSystem RCE for veterinary use.
The information provided typically includes the following:
- ProSystem RCE Indications
- Warnings and cautions for ProSystem RCE
- Direction and dosage information for ProSystem RCE
ProSystem RCEThis treatment applies to the following species:
Porcine Rotavirus Vaccine
Modified Live Virus
Clostridium Perfringens Type C-Escherichia Coli Bacterin-Toxoid
ProSystem RCE Indications
This product has been shown effective for the vaccination of healthy pregnant swine to provide passive immunity against rotaviral diarrhea, colibacillosis and enterotoxemia due to Rotavirus, Escherichia coli antigens (K88, K99, F41 and 987P) and Clostridium perfringens Type C toxoid in piglets. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.
This product has been shown to be effective against clinical diseases and mortality due to E. coli 987P in nursing piglets.
DOSAGE AND DIRECTIONS: Gently agitate bacterin-toxoid vial and use 10-15 mLs to rehydrate freeze dried vial. Transfer back into the bacterin-toxoid vial. Gently agitate vial and aseptically administer 2 mL dose intramuscularly to healthy pregnant swine at 5 weeks and again at 2 weeks before farrowing. In subsequent farrowings, administer 2 mL dose 2-3 weeks before farrowing.
CAUTIONS: Store in the dark at 2 to 8°C (35 to 46°F). Do not freeze. Fetal health risks associated with the vaccination of pregnant animals with this vaccine cannot be unequivocally determined during clinical trials conducted for licensure. Appropriate strategies to address the risks associated with vaccine use in pregnant animals should be discussed with a veterinarian. Conditions which interfere with lactation adversely affect immunity in baby pigs. Use entire contents when first opened. Do not mix with other products, except as specified on the label. Inactivate unused contents before disposal. Do not vaccinate within 21 days before slaughter. Anaphylactic reactions may occur following use. Antidote: Epinephrine. Contains gentamicin, thimerosal and polymyxin B as preservatives. In case of human exposure, contact a physician.
FOR ANIMAL USE ONLY
Intervet Inc., d/b/a Merck Animal Health, Omaha, NE 68103 USA
VLN 165A/PCN 49C1.21
For patent information:
2 GIRALDA FARMS, MADISON, NJ, 07940
|Technical Service (Companion Animal):||800-224-5318|
|Technical Service (Livestock):||800-211-3573|
Copyright © 2023 Animalytix LLC. Updated: 2023-02-28